tiprankstipranks
Trending News
More News >
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
Advertisement

Biodexa Pharmaceuticals (BDRX) Price & Analysis

Compare
511 Followers

BDRX Stock Chart & Stats


Biodexa Pharmaceuticals News

BDRX FAQ

What was Biodexa Pharmaceuticals’s price range in the past 12 months?
Biodexa Pharmaceuticals lowest stock price was $5.00 and its highest was $108.90 in the past 12 months.
    What is Biodexa Pharmaceuticals’s market cap?
    Biodexa Pharmaceuticals’s market cap is $3.93M.
      When is Biodexa Pharmaceuticals’s upcoming earnings report date?
      Biodexa Pharmaceuticals’s upcoming earnings report date is Apr 24, 2026 which is in 206 days.
        How were Biodexa Pharmaceuticals’s earnings last quarter?
        Biodexa Pharmaceuticals released its earnings results on Sep 12, 2025. The company reported $0 earnings per share for the quarter, beating the consensus estimate of -$0.004 by $0.004.
          Is Biodexa Pharmaceuticals overvalued?
          According to Wall Street analysts Biodexa Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Biodexa Pharmaceuticals pay dividends?
            Biodexa Pharmaceuticals does not currently pay dividends.
            What is Biodexa Pharmaceuticals’s EPS estimate?
            Biodexa Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Biodexa Pharmaceuticals have?
            Biodexa Pharmaceuticals has 619,523 shares outstanding.
              What happened to Biodexa Pharmaceuticals’s price movement after its last earnings report?
              Biodexa Pharmaceuticals reported an EPS of $0 in its last earnings report, beating expectations of -$0.004. Following the earnings report the stock price went up 1.518%.
                Which hedge fund is a major shareholder of Biodexa Pharmaceuticals?
                Currently, no hedge funds are holding shares in BDRX

                Company Description

                Biodexa Pharmaceuticals

                Biodexa Pharmaceuticals (BDRX) is a biotechnology company focused on the development and commercialization of innovative therapeutic solutions. Operating primarily in the pharmaceutical sector, the company specializes in the research and development of drug delivery systems and proprietary drug formulations designed to enhance patient outcomes. Its core products include advanced pharmaceutical compounds and delivery technologies that address unmet medical needs in various therapeutic areas.

                Biodexa Pharmaceuticals (BDRX) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Kazia Therapeutics
                Oragenics
                Xenetic Biosciences
                NLS Pharmaceutics
                Pasithea Therapeutics Corp

                Ownership Overview

                1.87%<0.01%<0.01%98.13%
                1.87%
                Insiders
                <0.01% Other Institutional Investors
                98.13% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis